S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ASAQ
Atlantic Avenue Acquisition
$10.03
$10.02
$9.78
$10.51
$250.75M-0.0255,003 shs141,340 shs
DA32 Life Science Tech Acquisition Corp. stock logo
DALS
DA32 Life Science Tech Acquisition
$10.32
+0.2%
$10.29
$9.68
$11.22
$264.71MN/A88,802 shs2,200 shs
FHLT
Future Health ESG
$12.70
-0.9%
$11.12
$9.97
$15.05
$75.44M-0.058,288 shs20,648 shs
SRSA
Sarissa Capital Acquisition
$10.05
$10.03
$9.72
$10.80
$251.25M-0.0554,101 shs7,304 shs
TCAC
Tuatara Capital Acquisition
$8.55
$9.15
$7.79
$9.99
$213.75M-0.0558,561 shs70,881 shs
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ASAQ
Atlantic Avenue Acquisition
0.00%0.00%0.00%0.00%0.00%
DA32 Life Science Tech Acquisition Corp. stock logo
DALS
DA32 Life Science Tech Acquisition
0.00%0.00%0.00%0.00%+1.57%
FHLT
Future Health ESG
+4.12%+3.36%+18.80%+20.03%+26.18%
SRSA
Sarissa Capital Acquisition
0.00%0.00%0.00%0.00%0.00%
TCAC
Tuatara Capital Acquisition
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ASAQ
Atlantic Avenue Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
DA32 Life Science Tech Acquisition Corp. stock logo
DALS
DA32 Life Science Tech Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
FHLT
Future Health ESG
N/AN/AN/AN/AN/AN/AN/AN/A
SRSA
Sarissa Capital Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
TCAC
Tuatara Capital Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ASAQ
Atlantic Avenue Acquisition
N/AN/AN/AN/A
DA32 Life Science Tech Acquisition Corp. stock logo
DALS
DA32 Life Science Tech Acquisition
N/AN/AN/AN/A
FHLT
Future Health ESG
N/AN/AN/AN/A
SRSA
Sarissa Capital Acquisition
N/AN/AN/AN/A
TCAC
Tuatara Capital Acquisition
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ASAQ
Atlantic Avenue Acquisition
N/AN/A$0.38 per share26.15($0.43) per shareN/A
DA32 Life Science Tech Acquisition Corp. stock logo
DALS
DA32 Life Science Tech Acquisition
N/AN/A$0.02 per share441.92($0.18) per shareN/A
FHLT
Future Health ESG
N/AN/AN/AN/A($1.56) per shareN/A
SRSA
Sarissa Capital Acquisition
N/AN/A$0.78 per share12.95($0.66) per shareN/A
TCAC
Tuatara Capital Acquisition
N/AN/A$0.28 per share30.33($0.69) per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ASAQ
Atlantic Avenue Acquisition
$9.59MN/A0.00N/AN/A-168.93%5.46%N/A
DA32 Life Science Tech Acquisition Corp. stock logo
DALS
DA32 Life Science Tech Acquisition
$600KN/A0.00N/AN/A-37.55%0.85%N/A
FHLT
Future Health ESG
-$50KN/A0.00N/AN/A-9.79%-0.28%N/A
SRSA
Sarissa Capital Acquisition
$19.40MN/A0.00N/AN/A-99.58%6.31%N/A
TCAC
Tuatara Capital Acquisition
$7.71MN/A0.00N/AN/A-123.64%6.48%N/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ASAQ
Atlantic Avenue Acquisition
N/AN/AN/AN/AN/A
DA32 Life Science Tech Acquisition Corp. stock logo
DALS
DA32 Life Science Tech Acquisition
N/AN/AN/AN/AN/A
FHLT
Future Health ESG
N/AN/AN/AN/AN/A
SRSA
Sarissa Capital Acquisition
N/AN/AN/AN/AN/A
TCAC
Tuatara Capital Acquisition
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ASAQ
Atlantic Avenue Acquisition
N/A
0.29
0.29
DA32 Life Science Tech Acquisition Corp. stock logo
DALS
DA32 Life Science Tech Acquisition
N/A
0.36
0.36
FHLT
Future Health ESG
N/A
0.02
0.02
SRSA
Sarissa Capital Acquisition
N/A
9.16
9.16
TCAC
Tuatara Capital Acquisition
N/A
0.28
0.28

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
ASAQ
Atlantic Avenue Acquisition
525.00 million21.00 millionNot Optionable
DA32 Life Science Tech Acquisition Corp. stock logo
DALS
DA32 Life Science Tech Acquisition
2,021N/AN/ANot Optionable
FHLT
Future Health ESG
2,0215.94 million2.54 millionNot Optionable
SRSA
Sarissa Capital Acquisition
625.00 millionN/ANot Optionable
TCAC
Tuatara Capital Acquisition
325.00 millionN/ANot Optionable

SRSA, ASAQ, FHLT, DALS, and TCAC Headlines

SourceHeadline
Cannabis marketing platform SpringBig secures approval to go publicCannabis marketing platform SpringBig secures approval to go public
finance.yahoo.com - July 11 at 8:16 AM

Media Sentiment Over Time

Company Descriptions

Atlantic Avenue Acquisition

NYSE:ASAQ
Atlantic Avenue Acquisition Corp does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, reorganization, recapitalization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Stamford, Connecticut.
DA32 Life Science Tech Acquisition logo

DA32 Life Science Tech Acquisition

NASDAQ:DALS
DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

Future Health ESG

NASDAQ:FHLT
Future Health ESG Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to pursue an initial business combination opportunity in the smart health technology sector. Future Health ESG Corp. was incorporated in 2021 and is based in Dover, Delaware.

Sarissa Capital Acquisition

NASDAQ:SRSA
Sarissa Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify and acquire a business, which focuses on the healthcare and biopharmaceutical industry. Sarissa Capital Acquisition Corp. was incorporated in 2020 and is based in Greenwich, Connecticut.

Tuatara Capital Acquisition

NASDAQ:TCAC
Tuatara Capital Acquisition Corporation focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in cannabis industry. Tuatara Capital Acquisition Corporation was incorporated in 2020 and is based in New York, New York.